- Home
- M vs HAE Comparison
M vs HAE Comparison
Compare M & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- M
- HAE
- Stock Information
- Founded
- M 1830
- HAE 1971
- Country
- M United States
- HAE United States
- Employees
- M N/A
- HAE N/A
- Industry
- M Department/Specialty Retail Stores
- HAE Medical/Dental Instruments
- Sector
- M Consumer Discretionary
- HAE Health Care
- Exchange
- M Nasdaq
- HAE Nasdaq
- Market Cap
- M 3.3B
- HAE 3.3B
- IPO Year
- M N/A
- HAE 1991
- Fundamental
- Price
- M $12.55
- HAE $76.87
- Analyst Decision
- M Hold
- HAE Strong Buy
- Analyst Count
- M 10
- HAE 10
- Target Price
- M $13.22
- HAE $98.50
- AVG Volume (30 Days)
- M 7.6M
- HAE 539.5K
- Earning Date
- M 08-20-2025
- HAE 08-07-2025
- Dividend Yield
- M 5.83%
- HAE N/A
- EPS Growth
- M N/A
- HAE 44.54
- EPS
- M 1.98
- HAE 3.31
- Revenue
- M $22,799,000,000.00
- HAE $1,360,824,000.00
- Revenue This Year
- M N/A
- HAE N/A
- Revenue Next Year
- M N/A
- HAE $7.18
- P/E Ratio
- M $6.32
- HAE $23.22
- Revenue Growth
- M N/A
- HAE 3.96
- 52 Week Low
- M $9.76
- HAE $55.30
- 52 Week High
- M $20.47
- HAE $94.99
- Technical
- Relative Strength Index (RSI)
- M 61.67
- HAE 73.55
- Support Level
- M $10.72
- HAE $73.86
- Resistance Level
- M $12.52
- HAE $76.95
- Average True Range (ATR)
- M 0.45
- HAE 1.58
- MACD
- M 0.16
- HAE 0.38
- Stochastic Oscillator
- M 97.06
- HAE 94.72
About M Macy's Inc
Founded in 1858 and based in New York City, Macy's operates about 450 stores under the Macy's nameplate, nearly 60 stores under the Bloomingdale's (full-price and outlet) and Bloomie's nameplates, and more than 170 freestanding Bluemercury specialty beauty stores. Macy's also operates e-commerce sites and licenses Bloomingdale's stores in the United Arab Emirates and Kuwait. Women's apparel, accessories, shoes, cosmetics, and fragrances constitute about 62% of Macy's sales.
About HAE Haemonetics Corporation
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.